Search

Author/Creator Wang, Michael L.

1. A phase I/II trial of the combination of lenalidomide, thalidomide and dexamethasone in relapsed and/or refractory multiple myeloma. Issue 12 (4th October 2019)

Authors:
Lee, Hans C.; Shah, Jatin J.; Feng, Lei; Morphey, Ashley; Johnson, Ralph J.; Wesson, Emily T.; Wang, Michael L.; Alexanian, Raymond; Thomas, Sheeba K.; Orlowski, Robert Z.; Weber, Donna M.
Journal:
American journal of hematology
Issue:
Volume 94:Issue 12(2019:Dec.)
Page Start:
E319
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase one trial of carfilzomib, bendamustine, and dexamethasone in relapsed and/or refractory multiple myeloma. Issue 7 (6th May 2021)

Authors:
Lee, Hans C.; Feng, Lei; Oriabure, Onyeka; Graham, Vivian; Chen, Wendy; Badillo, Maria; Lu, Rebecca; Lee, Hun J.; Jain, Preetesh; Manasanch, Elisabet E.; Orlowski, Robert Z.; Wang, Michael L.
Journal:
American journal of hematology
Issue:
Volume 96:Issue 7(2021)
Page Start:
E243
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. De novo CD5+ diffuse large B-cell lymphoma, NOS: clinical characteristics and outcomes in rituximab era. Issue 2 (28th January 2020)

Authors:
Hu, Bei; Nastoupil, Loretta J.; Loghavi, Sanam; Westin, Jason R.; Thakral, Beenu; Fayad, Luis E.; Hagemeister, Fredrick; Neelapu, Sattva; Samaniego, Felipe; Lee, Hun J.; Wang, Michael L.; Fanale, Michelle; Fowler, Nathan; Oki, Yasuhiro
Journal:
Leukemia & lymphoma
Issue:
Volume 61:Issue 2(2020)
Page Start:
328
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) ‐ outcomes and mutation profile from venetoclax resistant MCL patients. Issue 6 (17th April 2020)

Authors:
Zhao, Shuangtao; Kanagal‐Shamanna, Rashmi; Navsaria, Lucy; Ok, Chi Young; Zhang, Shaojun; Nomie, Krystle; Han, Guangchun; Hao, Dapeng; Hill, Holly A.; Jiang, Changying; Yao, Yixin; Nastoupil, Loretta; Westin, Jason; Fayad, Luis; Nair, Ranjit; Steiner, Raphel; Ahmed, Sairah; Samaniego, Felipe; Iye...
Journal:
American journal of hematology
Issue:
Volume 95:Issue 6(2020:Jun.)
Page Start:
623
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Four‐year follow‐up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL). (22nd May 2018)

Authors:
Jain, Preetesh; Romaguera, Jorge; Srour, Samer A.; Lee, Hun J.; Hagemeister, Frederick; Westin, Jason; Fayad, Luis; Samaniego, Felipe; Badillo, Maria; Zhang, Liang; Nastoupil, Lorreta; Kanagal‐Shamanna, Rashmi; Fowler, Nathan; Wang, Michael L.
Journal:
British journal of haematology
Issue:
Volume 182:Number 3(2018)
Page Start:
404
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma. Issue 2 (10th January 2022)

Authors:
Jain, Preetesh; Zhao, Shuangtao; Lee, Hun Ju; Hill, Holly A.; Ok, Chi Young; Kanagal-Shamanna, Rashmi; Hagemeister, Fredrick B.; Fowler, Nathan; Fayad, Luis; Yao, Yixin; Liu, Yang; Moghrabi, Omar B.; Navsaria, Lucy; Feng, Lei; Nogueras Gonzalez, Graciela M.; Xu, Guofan; Thirumurthi, Selvi; Santos...
Journal:
Journal of clinical oncology
Issue:
Volume 40:Issue 2(2022)
Page Start:
202
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗